Rapid Micro Biosystems (NASDAQ:RPID) Announces Earnings Results, Hits Estimates

Rapid Micro Biosystems (NASDAQ:RPID) issued its quarterly earnings data on Friday. The company reported ($0.22) EPS for the quarter, hitting the consensus estimate of ($0.22), Zacks reports. Rapid Micro Biosystems had a negative net margin of 184.93% and a negative return on equity of 48.05%. Rapid Micro Biosystems updated its FY 2025 guidance to EPS.

Rapid Micro Biosystems Stock Performance

Shares of Rapid Micro Biosystems stock traded down $0.59 during trading on Friday, hitting $2.72. The company’s stock had a trading volume of 8,162,743 shares, compared to its average volume of 628,774. Rapid Micro Biosystems has a 52 week low of $0.58 and a 52 week high of $4.04. The company has a market capitalization of $117.01 million, a PE ratio of -2.43 and a beta of 1.25. The company has a fifty day simple moving average of $1.91 and a two-hundred day simple moving average of $1.29.

Analyst Upgrades and Downgrades

Separately, KeyCorp assumed coverage on Rapid Micro Biosystems in a research note on Wednesday, February 12th. They issued an “overweight” rating and a $8.00 target price for the company.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.